Achilles Therapeutics (ACHL)
1.48
0.00 (0.00%)
At close: Mar 20, 2025, 3:59 PM
13F Institute Ownership
Total Institutes of 21 in Achilles Therapeutics reduced their positions with a decrease of 1 investors compared to the previous quarter. A reduction of 40.99K shares, as total invested capital grew by $2.9M with ownership percentage dropping from 60.20% to 60.10%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Syncona Portfolio Ltd | 27.42% | 11.09M | +0.00% | 12.64M | 23.86% |
| Bml Capital Management, LLC | 10.14% | 4.1M | +0.00% | 4.67M | 2.90% |
| Fcpm Iii Services B.v. | 5.91% | 2.39M | +0.00% | 2.75M | 0.46% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.